Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Schizophrenia

  Free Subscription


Articles published in J Clin Psychiatry

Retrieve available abstracts of 91 articles:
HTML format



Single Articles


    August 2024
  1. CORRELL CU, Xiang P, Sarikonda K, Bhagvandas N, et al
    The Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia: A Targeted Literature Review With a Focus on Outcomes Relevant to Health Care Decision-Makers in the United States.
    J Clin Psychiatry. 2024;85:24r15316.
    PubMed     Abstract available


  2. KINON BJ, Leucht S, Tamminga C, Breier A, et al
    Rationale for Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia.
    J Clin Psychiatry. 2024;85:23nr15240.
    PubMed     Abstract available


  3. SOMMI RW, Saklad SR, Weiden PJ, Still D, et al
    Initiating Aripiprazole Lauroxil: Post Hoc Analysis of Safety and Tolerability of 1-Day and 21-Day Regimens.
    J Clin Psychiatry. 2024;85:23m15132.
    PubMed     Abstract available


    June 2024
  4. VACCARINO SR, Vaccarino AL
    Cognitive Effects of Electroconvulsive Therapy in Schizophrenia: A Systematic Review.
    J Clin Psychiatry. 2024;85:23r15045.
    PubMed     Abstract available


    May 2024
  5. KOBYLSKI LA, Le HN, Freeman MP, Cohen LS, et al
    Enhancing Postpartum Psychosis Care With Qualitative Research: Current Findings and Future Directions.
    J Clin Psychiatry. 2024;85:24com15305.
    PubMed    


  6. NASRALLAH HA
    Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma.
    J Clin Psychiatry. 2024;85:24com15310.
    PubMed    


  7. CUNAT O, Arranz B, Vila-Badia R, Serra-Arumi C, et al
    Relationship Between Exposure to Emotional Neglect and the Inflammatory Biomarkers Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, and Platelet-to-Lymphocyte Ratios in Patients With First-Episode Psychosis.
    J Clin Psychiatry. 2024;85:23m15141.
    PubMed     Abstract available


  8. BRAINERD DR, Alexander B, Tague MJ, Lund BC, et al
    Association Between Clozapine Exposure and Risk of Hematologic Malignancies in Veterans With Schizophrenia.
    J Clin Psychiatry. 2024;85:23m15149.
    PubMed     Abstract available


  9. ANDRADE C
    Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
    J Clin Psychiatry. 2024;85:24f15363.
    PubMed     Abstract available


  10. TIEN Y, Wang XY, Huang SC, Huang HP, et al
    Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study.
    J Clin Psychiatry. 2024;85:23m15071.
    PubMed     Abstract available


    April 2024
  11. SIMON GE, Rossom RC, Iturralde E, Ahmedani BK, et al
    Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine.
    J Clin Psychiatry. 2024;85:23m14833.
    PubMed     Abstract available


    February 2024
  12. CITROME L, Yagoda S, Bidollari I, Wang M, et al
    Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophre
    J Clin Psychiatry. 2024;85:23m15095.
    PubMed     Abstract available


    January 2024
  13. MIURA I, Sano F, Sakaguchi R, Okamoto K, et al
    Effect of Lurasidone on Social Functioning in Schizophrenia: Post Hoc Analysis of the JEWEL Study.
    J Clin Psychiatry. 2024;85:23m14881.
    PubMed     Abstract available


  14. ITURRALDE E, Fazzolari L, Slama NE, Alexeeff SE, et al
    Telehealth Collaborative Care Led by Clinical Pharmacists for People With Psychosis or Bipolar Disorder: A Propensity Weighted Comparison With Usual Psychiatric Care.
    J Clin Psychiatry. 2024;85:23m14917.
    PubMed     Abstract available


    November 2023
  15. LONDON SM, Cawkwell PB, Shinn AK
    Medication Adherence in a Transdiagnostic First-Episode Psychosis Sample.
    J Clin Psychiatry. 2023;84:23m14947.
    PubMed     Abstract available


    October 2023
  16. VERGARA L, de la Serna E, Sugranyes G, Puig O, et al
    Obsessive-Compulsive Spectrum Symptoms Are Associated With Functional Impairment in Children and Adolescents With Psychosis Risk Syndrome: The CAPRIS Study.
    J Clin Psychiatry. 2023;84:22m14698.
    PubMed     Abstract available


    September 2023
  17. LOPENA OJ, Alphs LD, Sajatovic M, Turkoz I, et al
    Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis.
    J Clin Psychiatry. 2023;84:23m14788.
    PubMed     Abstract available


  18. CHENG CM, Chang WH, Tsai SJ, Li CT, et al
    Risk of All-Cause and Suicide Death in Patients With Schizophrenia: An Entire-Population Longitudinal Study in Taiwan.
    J Clin Psychiatry. 2023;84:22m14747.
    PubMed     Abstract available


  19. CITROME L, Such P, Yildirim M, Madera-McDonough J, et al
    Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
    J Clin Psychiatry. 2023;84:23m14873.
    PubMed     Abstract available


    August 2023
  20. LAW C, See YM, Yee JY, Ng BT, et al
    The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
    J Clin Psychiatry. 2023;84:22m14588.
    PubMed     Abstract available


  21. MARTINS R, Kadakia A, Williams GR, Milanovic S, et al
    The Lifetime Burden of Schizophrenia as Estimated by a Government-Centric Fiscal Analytic Framework.
    J Clin Psychiatry. 2023;84:22m14746.
    PubMed     Abstract available


  22. CITROME L, Meyer JM
    Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management.
    J Clin Psychiatry. 2023;84:sunscz3001sho.
    PubMed     Abstract available


    July 2023
  23. WESNER K, Hiemke C, Bergemann N, Egberts KM, et al
    Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor Occupancy.
    J Clin Psychiatry. 2023;84:22r14626.
    PubMed     Abstract available


  24. ZHANG T, Xiao X, Wu H, Zeng J, et al
    Association of Attenuated Niacin Response With Inflammatory Imbalance and Prediction of Conversion to Psychosis From Clinical High-risk Stage.
    J Clin Psychiatry. 2023;84:22m14731.
    PubMed     Abstract available


  25. ROSSOM RC, Crain AL, Waring S, Sperl-Hillen JM, et al
    Differential Effects of an Intervention to Reduce Cardiovascular Risk for Patients With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Randomized Clinical Trial.
    J Clin Psychiatry. 2023;84:22m14710.
    PubMed     Abstract available


    April 2023
  26. KANE JM, Mychaskiw MA, Lim S, Suett M, et al
    Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia.
    J Clin Psychiatry. 2023;84:22m14544.
    PubMed     Abstract available


  27. JAIN R, Ayyagari R, Goldschmidt D, Zhou M, et al
    Impact of Tardive Dyskinesia on Physical, Psychological, Social, and Professional Domains of Patient Lives: A Survey of Patients in the United States.
    J Clin Psychiatry. 2023;84:22m14694.
    PubMed     Abstract available


    March 2023
  28. NASIB LG, Winter-van Rossum I, Zuithoff NPA, Boudewijns ZSRM, et al
    Generalizability of the Results of Efficacy Trials in First-Episode Schizophrenia: Comparing Outcome and Study Discontinuation of Groups of Participants in the Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial.
    J Clin Psychiatry. 2023;84:22m14531.
    PubMed     Abstract available


  29. KAHN RS, Kane JM, Correll CU, Arevalo C, et al
    Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study.
    J Clin Psychiatry. 2023;84:22m14674.
    PubMed     Abstract available


  30. IZQUIERDO A, Cabello M, Leal I, Torio I, et al
    Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study.
    J Clin Psychiatry. 2023;84:22m14401.
    PubMed     Abstract available


  31. CITROME L, Durgam S, Edwards JB, Davis RE, et al
    Lumateperone for the Treatment of Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed.
    J Clin Psychiatry. 2023;84:22r14631.
    PubMed     Abstract available


  32. TAYLOR CL, Brown HK, Saunders NR, Barker LC, et al
    Preventive Health Care Among Children of Women With Schizophrenia: A Population-Based Cohort Study.
    J Clin Psychiatry. 2023;84:22m14497.
    PubMed     Abstract available


    February 2023
  33. RUBIO JM, Mychaskiw MA, Lim S, Suett M, et al
    Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia.
    J Clin Psychiatry. 2023;84:22m14604.
    PubMed     Abstract available


  34. SABE M, Pallis K, Solmi M, Crippa A, et al
    Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis.
    J Clin Psychiatry. 2023;84:22r14490.
    PubMed     Abstract available


    January 2023
  35. ANDRADE C
    Prolactin-Raising and Prolactin-Sparing Antipsychotic Drugs and the Risk of Fracture and Fragility Fracture in Patients With Schizophrenia, Dementia, and Other Disorders.
    J Clin Psychiatry. 2023;84:23f14790.
    PubMed     Abstract available


  36. VELLIGAN DI, Rao S
    Defining and Achieving Treatment Recovery in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM6.
    PubMed    


  37. VELLIGAN DI, Rao S
    Optimizing Therapy Selection, Sequencing in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM9.
    PubMed    


  38. VELLIGAN DI, Rao S
    The Epidemiology and Global Burden of Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM5.
    PubMed    


  39. VELLIGAN DI, Rao S
    Adverse Events and Treatment Adherence in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM8.
    PubMed    


  40. VELLIGAN DI, Rao S
    Schizophrenia: Salient Symptoms and Pathophysiology.
    J Clin Psychiatry. 2023;84:MS21078COM7.
    PubMed    


  41. VELLIGAN DI, Rao S
    The Emerging Treatment Landscape in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM10.
    PubMed    


    December 2022
  42. AMSALEM D, Jankowski SE, Pagdon S, Valeri L, et al
    "It Is Hard to Be a Woman With Schizophrenia": Randomized Controlled Trial of a Brief Video Intervention to Reduce Public Stigma in Young Adults.
    J Clin Psychiatry. 2022;84:22m14534.
    PubMed     Abstract available


    November 2022
  43. NELSON EB, Franco OH, Patton BA, Schmidt LR, et al
    Telehealth of Coordinated Specialty Care in Early Psychosis During COVID-19.
    J Clin Psychiatry. 2022;84:21m14259.
    PubMed     Abstract available


    October 2022
  44. KADAKIA A, Catillon M, Fan Q, Williams GR, et al
    The Economic Burden of Schizophrenia in the United States.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  45. CITROME L, Preskorn SH, Lauriello J, Krystal JH, et al
    Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


    September 2022
  46. AHN ROBINS D, Grootendorst-van NH, Chang CK, Chandran D, et al
    Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  47. ANDRADE C
    Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


    August 2022
  48. CORRELL CU, Ismail Z, McIntyre RS, Rafeyan R, et al
    Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  49. MISAWA F, Fujii Y, Takeuchi H
    Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  50. CORRELL CU, Ismail Z, McIntyre RS, Rafeyan R, et al
    Patient Functioning and Life Engagement: Unmet Needs in Major Depressive Disorder and Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  51. LEVI L, Zamora D, Nastas I, Gonen I, et al
    Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


    July 2022
  52. SCHORETSANITIS G, de Leon J
    Best Practices for Starting Clozapine in Patients With Schizophrenia: How to Switch From the Prior Antipsychotic(s).
    J Clin Psychiatry. 2022;83.
    PubMed    


    June 2022
  53. CITROME L, Komaroff M, Starling B, Byreddy S, et al
    Efficacy of HP-3070, an Asenapine Transdermal System, on Symptoms of Hostility in Adults With Schizophrenia: A Post Hoc Analysis of a 6-Week Phase 3 Study.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  54. FANG SC, Huang CY, Shao YJ
    Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


    May 2022
  55. ZHENG S, Lee J, Chan SKW
    Utility and Barriers to Clozapine Use: A Joint Study of Clinicians' Attitudes From Singapore and Hong Kong.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  56. WEIDEN PJ, Breier A, Kavanagh S, Miller AC, et al
    Antipsychotic Efficacy of KarXT (Xanomeline-Trospium): Post Hoc Analysis of Positive and Negative Syndrome Scale Categorical Response Rates, Time Course of Response, and Symptom Domains of Response in a Phase 2 Study.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


    April 2022
  57. COHEN EA, Skubiak T, Hadzi Boskovic D, Norman K, et al
    Phase 3b Multicenter, Prospective, Open-label Trial to Evaluate the Effects of a Digital Medicine System on Inpatient Psychiatric Hospitalization Rates for Adults With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


    March 2022
  58. SAWAGASHIRA R, Yamamura R, Okubo R, Hashimoto N, et al
    Subthreshold Change in Glycated Hemoglobin and Body Mass Index After the Initiation of Second-Generation Antipsychotics Among Patients With Schizophrenia or Bipolar Disorder: A Nationwide Prospective Cohort Study in Japan.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  59. ZENG J, Raballo A, Gan R, Wu G, et al
    Antipsychotic Exposure in Clinical High Risk of Psychosis: Empirical Insights From a Large Cohort Study.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  60. HUANG N, Wang PS, Chen CY, Bai YM, et al
    Influence of Care Delivery Models on Quality of Diabetes Care Among Individuals With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  61. CORRELL CU, He Y, Therrien F, MacKenzie E, et al
    Effects of Brexpiprazole on Functioning in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  62. SCHOOLER NR
    Functional Outcomes of an Antipsychotic Medication in Schizophrenia: A Generalizable or Specific Effect?
    J Clin Psychiatry. 2022;83.
    PubMed    


    February 2022
  63. CORRELL CU, Abi-Dargham A, Howes O
    Emerging Treatments in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


  64. LUI SSY, Zhang RT, Lau WYS, Liu ACY, et al
    Prospective Memory Influences Social Functioning in People With First-Episode Schizophrenia: A Network Analysis and Longitudinal Study.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available


    December 2021
  65. WANG H, Zhang Y, Liu J, Chi R, et al
    Persistence With and Adherence to Paliperidone Palmitate Once-Monthly Injection for Schizophrenia Treatment in China and Japan.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available


  66. WANG W, Chau AKC, Kong P, Sun X, et al
    Efficacy of Motivational Interviewing in Treating Co-occurring Psychosis and Substance Use Disorder: A Systematic Review and Meta-Analysis.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available


  67. KIKKERT MJ, de Mooij L, de Koning M, Dekker J, et al
    Subjective Medication Satisfaction With Antipsychotic Polypharmacy in a Naturalistic Inpatient and Outpatient Sample.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available


  68. BEEX-OOSTERHUIS MM, Van Gool AR, Heerdink ER, van Kesteren C, et al
    Clozapine Treatment During Pregnancy and the Postpartum Period: A Systematic Literature Review.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available


  69. KU BS, Compton MT, Walker EF, Druss BG, et al
    Social Fragmentation and Schizophrenia: A Systematic Review.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available


    November 2021
  70. RUBIO JM, Kane JM
    How to Make an Effective Offer of Clozapine.
    J Clin Psychiatry. 2021;83.
    PubMed    


  71. TAKAHASHI K, Uchida H, Suzuki T, Mimura M, et al
    Comorbid Psychiatric Disorders in Patients Hospitalized for Pulmonary Embolism and Acute Myocardial Infarction: A Japanese Nationwide Database Study.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available


    September 2021
  72. LE MOIGNE A, Csernansky J, Leadbetter RA, Andorn AC, et al
    PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  73. BAEZA I, de la Serna E, Amoretti S, Cuesta MJ, et al
    Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  74. CORRELL CU, Howes OD
    Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  75. CHENG CM, Chen MH, Chang WH, Tsai CF, et al
    Risks of Coaggregation of Major Psychiatric Disorders Among First-Degree Relatives of Patients With Bipolar I and Bipolar II Disorder: Evidence From a Nationwide Population-Based Study.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


    August 2021
  76. OKUSAGA OO, Mitchell BG, Bernard JD, Walder A, et al
    Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia or Schizoaffective Disorder.
    J Clin Psychiatry. 2021;82.
    PubMed    


    July 2021
  77. CHEN MH, Pan TL, Bai YM, Huang KL, et al
    Postpartum Depression and Psychosis and Subsequent Severe Mental Illnesses in Mothers and Neurodevelopmental Disorders in Children: A Nationwide Study.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  78. ZUSCHLAG ZD
    Second-Generation Antipsychotics and Suicide: A Commentary.
    J Clin Psychiatry. 2021;82.
    PubMed    


  79. VERAART JKE, Smith-Apeldoorn SY, Spijker J, Kamphuis J, et al
    Ketamine Treatment for Depression in Patients With a History of Psychosis or Current Psychotic Symptoms: A Systematic Review.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  80. BALLARD C, Aarsland D
    Relieving Caregiver Burden Through Evidence-Based Treatment for Dementia-Related Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


    June 2021
  81. STEINERT T, Jans F
    Six Cases of Perforated Appendicitis During Clozapine Treatment.
    J Clin Psychiatry. 2021;82.
    PubMed    


    May 2021
  82. GRUBAUGH AL, Brown WJ, Wojtalik JA, Myers US, et al
    Meta-Analysis of the Treatment of Posttraumatic Stress Disorder in Adults With Comorbid Severe Mental Illness.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  83. DUBREUCQ M, Plasse J, Gabayet F, Blanc O, et al
    Sex Differences in Recovery-Related Outcomes and Needs for Psychiatric Rehabilitation in People With Schizophrenia Spectrum Disorder.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  84. SHINN AK, Carol EE
    The Importance of Context in Identifying the Recovery Needs of Women With Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed    


  85. CHEN YQ, Li XR, Zhang L, Zhu WB, et al
    Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  86. HARVEY PD, Kane JM
    Addressing Patients' Unmet Needs to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


    April 2021
  87. BALLARD C
    Evidence-Based Treatment and Monitoring Strategies for Dementia-Related Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


    March 2021
  88. KANE JM
    Lessening the Side Effect Burden to Improve Adherence Among Individuals With Schizophrenia.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  89. HARVEY PD
    Patient-Centered Treatment Strategies to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  90. MILLER BJ, McEvoy JP, McCall WV
    Insomnia, Suicidal Ideation, and Suicide Attempts in the Clinical Antipsychotic Trials of Intervention Effectiveness.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


    February 2021
  91. BELL KS, Henderson DC, Wright HJ, Gogate JP, et al
    Treatment Effect With Paliperidone Palmitate Compared With Oral Antipsychotics in Black/African American Patients With Schizophrenia and a History of Criminal Justice System Involvement: A Post Hoc Analysis of the PRIDE Study.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.